Nerve growth factor and autophagy

Effect of nasal anti-NGF-antibodies administration on Ambra1 and Beclin-1 expression in rat brain

Pamela Rosso, Sandra Moreno, Anna Fracassi, Maria Luisa Rocco, Luigi Aloe

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Nerve growth factor (NGF) exerts protective actions in the healthy and diseased nervous system. Intranasal administration is a suitable and safe strategy to deliver NGF to CNS neurons. We investigated whether nasal anti-NGF-antibody (ANA) administration affects neuronal autophagy, in view of its putative regulatory role in this process. We focused on olfactory bulbs (OB), neocortex (Cx), hippocampus (HF) and septal complex (SC), known to be NGF-responsive and autophagically active. Our combined molecular/morphological results demonstrate that intranasally administered ANA reaches brain NGF-target neurons and lowers the levels of endogenous NGF and its receptors. Treatment also affects - in a brain region-dependent manner - the expression of the autophagic proteins Beclin-1 and Ambra1, as well as that of proteins belonging to the Bcl2 family, namely Bax and Bcl-2, reflecting apoptotic dysregulation. This study provides a nongenetically modified, NGF-defective animal model, representing a suitable tool to investigate novel properties of the neurotrophin, especially in relation to autophagy.

Original languageEnglish (US)
Pages (from-to)401-409
Number of pages9
JournalGrowth Factors
Volume33
Issue number5-6
DOIs
StatePublished - Sep 3 2015
Externally publishedYes

Fingerprint

Autophagy
Nerve Growth Factor
Nose
Rats
Brain
Antibodies
Neurons
Nerve Growth Factor Receptors
Intranasal Administration
Olfactory Bulb
Neocortex
Nerve Growth Factors
Neurology
Beclin-1
Nervous System Diseases
Anti-Idiotypic Antibodies
Hippocampus
Animals
Proteins
Animal Models

Keywords

  • Ambra1
  • Anti-NGF-antibodies (ANA)
  • Autophagy
  • Beclin-1
  • Nasal administration
  • Nerve growth factor (NGF)

ASJC Scopus subject areas

  • Endocrinology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Nerve growth factor and autophagy : Effect of nasal anti-NGF-antibodies administration on Ambra1 and Beclin-1 expression in rat brain. / Rosso, Pamela; Moreno, Sandra; Fracassi, Anna; Rocco, Maria Luisa; Aloe, Luigi.

In: Growth Factors, Vol. 33, No. 5-6, 03.09.2015, p. 401-409.

Research output: Contribution to journalArticle

Rosso, Pamela ; Moreno, Sandra ; Fracassi, Anna ; Rocco, Maria Luisa ; Aloe, Luigi. / Nerve growth factor and autophagy : Effect of nasal anti-NGF-antibodies administration on Ambra1 and Beclin-1 expression in rat brain. In: Growth Factors. 2015 ; Vol. 33, No. 5-6. pp. 401-409.
@article{6f4528fa871e4f869ca46665267d0278,
title = "Nerve growth factor and autophagy: Effect of nasal anti-NGF-antibodies administration on Ambra1 and Beclin-1 expression in rat brain",
abstract = "Nerve growth factor (NGF) exerts protective actions in the healthy and diseased nervous system. Intranasal administration is a suitable and safe strategy to deliver NGF to CNS neurons. We investigated whether nasal anti-NGF-antibody (ANA) administration affects neuronal autophagy, in view of its putative regulatory role in this process. We focused on olfactory bulbs (OB), neocortex (Cx), hippocampus (HF) and septal complex (SC), known to be NGF-responsive and autophagically active. Our combined molecular/morphological results demonstrate that intranasally administered ANA reaches brain NGF-target neurons and lowers the levels of endogenous NGF and its receptors. Treatment also affects - in a brain region-dependent manner - the expression of the autophagic proteins Beclin-1 and Ambra1, as well as that of proteins belonging to the Bcl2 family, namely Bax and Bcl-2, reflecting apoptotic dysregulation. This study provides a nongenetically modified, NGF-defective animal model, representing a suitable tool to investigate novel properties of the neurotrophin, especially in relation to autophagy.",
keywords = "Ambra1, Anti-NGF-antibodies (ANA), Autophagy, Beclin-1, Nasal administration, Nerve growth factor (NGF)",
author = "Pamela Rosso and Sandra Moreno and Anna Fracassi and Rocco, {Maria Luisa} and Luigi Aloe",
year = "2015",
month = "9",
day = "3",
doi = "10.3109/08977194.2015.1122002",
language = "English (US)",
volume = "33",
pages = "401--409",
journal = "Growth Factors",
issn = "0897-7194",
publisher = "Informa Healthcare",
number = "5-6",

}

TY - JOUR

T1 - Nerve growth factor and autophagy

T2 - Effect of nasal anti-NGF-antibodies administration on Ambra1 and Beclin-1 expression in rat brain

AU - Rosso, Pamela

AU - Moreno, Sandra

AU - Fracassi, Anna

AU - Rocco, Maria Luisa

AU - Aloe, Luigi

PY - 2015/9/3

Y1 - 2015/9/3

N2 - Nerve growth factor (NGF) exerts protective actions in the healthy and diseased nervous system. Intranasal administration is a suitable and safe strategy to deliver NGF to CNS neurons. We investigated whether nasal anti-NGF-antibody (ANA) administration affects neuronal autophagy, in view of its putative regulatory role in this process. We focused on olfactory bulbs (OB), neocortex (Cx), hippocampus (HF) and septal complex (SC), known to be NGF-responsive and autophagically active. Our combined molecular/morphological results demonstrate that intranasally administered ANA reaches brain NGF-target neurons and lowers the levels of endogenous NGF and its receptors. Treatment also affects - in a brain region-dependent manner - the expression of the autophagic proteins Beclin-1 and Ambra1, as well as that of proteins belonging to the Bcl2 family, namely Bax and Bcl-2, reflecting apoptotic dysregulation. This study provides a nongenetically modified, NGF-defective animal model, representing a suitable tool to investigate novel properties of the neurotrophin, especially in relation to autophagy.

AB - Nerve growth factor (NGF) exerts protective actions in the healthy and diseased nervous system. Intranasal administration is a suitable and safe strategy to deliver NGF to CNS neurons. We investigated whether nasal anti-NGF-antibody (ANA) administration affects neuronal autophagy, in view of its putative regulatory role in this process. We focused on olfactory bulbs (OB), neocortex (Cx), hippocampus (HF) and septal complex (SC), known to be NGF-responsive and autophagically active. Our combined molecular/morphological results demonstrate that intranasally administered ANA reaches brain NGF-target neurons and lowers the levels of endogenous NGF and its receptors. Treatment also affects - in a brain region-dependent manner - the expression of the autophagic proteins Beclin-1 and Ambra1, as well as that of proteins belonging to the Bcl2 family, namely Bax and Bcl-2, reflecting apoptotic dysregulation. This study provides a nongenetically modified, NGF-defective animal model, representing a suitable tool to investigate novel properties of the neurotrophin, especially in relation to autophagy.

KW - Ambra1

KW - Anti-NGF-antibodies (ANA)

KW - Autophagy

KW - Beclin-1

KW - Nasal administration

KW - Nerve growth factor (NGF)

UR - http://www.scopus.com/inward/record.url?scp=84955195280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955195280&partnerID=8YFLogxK

U2 - 10.3109/08977194.2015.1122002

DO - 10.3109/08977194.2015.1122002

M3 - Article

VL - 33

SP - 401

EP - 409

JO - Growth Factors

JF - Growth Factors

SN - 0897-7194

IS - 5-6

ER -